OP-401

N/A

Report date: 2023/05/11 13:42:19

Base Information

Drug NameOP-401
Drug Alias NameOP-401
ClassificationSmall molecules
Mechanisms of ActionProstate-Specific Membrane Antigen inhibitors
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsAmyotrophic Lateral SclerosisMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAshvattha Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesOrpheris Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A